| 前收市價 | 390.65 |
| 開市 | 389.20 |
| 買盤 | 390.15 x 0 |
| 賣出價 | 390.55 x 0 |
| 今日波幅 | 389.20 - 389.20 |
| 52 週波幅 | 300.00 - 407.10 |
| 成交量 | |
| 平均成交量 | 0 |
| 市值 | 無 |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | 無 |
| 業績公佈日 | 2024年7月30日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
Investor's Business DailyDow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.
Insider MonkeyWall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts. If you want to see more such stocks on the list, go directly to Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets. On May 8, the S&P 500 faced resistance after a four-day winning […]
